Medicare & Medicaid
Under a proposed rule, different methods would be tried in selected geographic areas over a five-year test period. Some of these experiments would begin this year, with others added in 2017. The proposal faces two months of public comment.
Over 300 healthcare and patient advocacy organizations sent a letter to Senate and House leaders on Thursday urging them to press the Centers for Medicare and Medicaid Services to permanently withdraw a reduced Part B drug payment model from consideration.
While the Centers for Medicare and Medicaid Services is touting the success -- 11 months ahead of schedule -- of tying 30 percent of fee-for-service Medicare payments to alternative payment models such as accountable care organizations and bundled payments, questions still remain over how much money value-based programs will save.
The House Ways and Means Health Subcommittee held a bipartisan debate Wednesday over the future of Medicare and planned cuts to the Medicare Advantage program as sharp party divides over healthcare continue to widen.
Under the new system, CMS estimates it saved Medicare approximately $3.6 billion between 2013 and 2015.
Isaac Kojo Anakwah Thompson, a Florida doctor who falsely diagnosed hundreds of patients as having a rare spine condition, has pleaded guilty to healthcare fraud and faces spending a decade in prison.
The following database lists the individual skilled nursing facilities, their total number of stays, average length of stays, total charges, Medicare payments and Medicare allowances.
The Centers for Medicare and Medicaid Services is scrapping its policy of automatically reducing the star ratings for contracts under sanction, a decision that affects the bonus payments and rebates for plans in a state of penalty.
The Centers for Medicare and Medicaid Services on Wednesday released data on 15,055 skilled nursing facilities, over 2.5 million stays, and almost $27 billion in Medicare payments for 2013.
The current Medicare Part B drug payment methodology can penalize doctors for selecting lower-cost drugs.